Clinical trials
Phase 3 Dyslipidemias trials in Bulgaria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| 89bio, Inc. | 1 |
| Amgen | 1 |
| Kowa Research Institute, Inc. | 1 |
| Takeda | 1 |
| Tanabe Pharma Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 7 |
| Hypercholesterolemia | 3 |
| Hyperlipidemias | 3 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Coronary Stenosis | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Lipoatrophic | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.